In fact, SP, a neurotransmitter able to regulate the tumor microenvironment via the neurokinin-1 receptor (NK-1R), is supposed to activate normal HSCs to aHSCs through the SP/NK-1R signal pathway [106], while CAPS is mentioned as an SP inhibitor [107]. Here, TACR1 is linked to neoplasm.